Company Details
biomerieux
12,827
397,670
541714
biomerieux.com
174
BIO_1694400
Completed


bioMérieux Vendor Cyber Rating & Cyber Score
biomerieux.comA family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.
Company Details
biomerieux
12,827
397,670
541714
biomerieux.com
174
BIO_1694400
Completed
Between 750 and 799

bioMérieux Global Score (TPRM)XXXX

Description: The bioMérieux company reported a data breach involving its vendor, Vitality Group, on June 28, 2023. The breach occurred due to unauthorized access to personal information through a vulnerability in the MOVEit Transfer application on June 1, 2023, affecting social security numbers, health information, and personal details of members. The number of individuals affected is currently unknown.


No incidents recorded for bioMérieux in 2026.
No incidents recorded for bioMérieux in 2026.
No incidents recorded for bioMérieux in 2026.
bioMérieux cyber incidents detection timeline including parent company and subsidiaries

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
.png)
Jones Day recently hosted a webinar in which trade secrets lawyers provided tips for protecting trade secrets from today's threats.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of bioMérieux is https://www.biomerieux.com.
According to Rankiteo, bioMérieux’s AI-generated cybersecurity score is 786, reflecting their Fair security posture.
According to Rankiteo, bioMérieux currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, bioMérieux has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
According to Rankiteo, bioMérieux is not certified under SOC 2 Type 1.
According to Rankiteo, bioMérieux does not hold a SOC 2 Type 2 certification.
According to Rankiteo, bioMérieux is not listed as GDPR compliant.
According to Rankiteo, bioMérieux does not currently maintain PCI DSS compliance.
According to Rankiteo, bioMérieux is not compliant with HIPAA regulations.
According to Rankiteo,bioMérieux is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
bioMérieux operates primarily in the Biotechnology Research industry.
bioMérieux employs approximately 12,827 people worldwide.
bioMérieux presently has no subsidiaries across any sectors.
bioMérieux’s official LinkedIn profile has approximately 397,670 followers.
bioMérieux is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
No, bioMérieux does not have a profile on Crunchbase.
Yes, bioMérieux maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biomerieux.
As of April 02, 2026, Rankiteo reports that bioMérieux has experienced 1 cybersecurity incidents.
bioMérieux has an estimated 4,635 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability.
Title: bioMérieux Data Breach
Description: The bioMérieux company reported a data breach involving its vendor, Vitality Group, on June 28, 2023. The breach occurred due to unauthorized access to personal information through a vulnerability in the MOVEit Transfer application on June 1, 2023, affecting social security numbers, health information, and personal details of members. The number of individuals affected is currently unknown.
Date Detected: 2023-06-01
Date Publicly Disclosed: 2023-06-28
Type: Data Breach
Attack Vector: Unauthorized Access
Vulnerability Exploited: MOVEit Transfer application vulnerability
Common Attack Types: The most common types of attacks the company has faced is Vulnerability.

Data Compromised: Social security numbers, Health information, Personal details
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Social Security Numbers, Health Information, Personal Details and .

Type of Data Compromised: Social security numbers, Health information, Personal details

Source: bioMérieux
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: bioMérieux.
Most Recent Incident Detected: The most recent incident detected was on 2023-06-01.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2023-06-28.
Most Significant Data Compromised: The most significant data compromised in an incident were Social Security Numbers, Health Information, Personal Details and .
Most Sensitive Data Compromised: The most sensitive data compromised in a breach were Health Information, Social Security Numbers and Personal Details.
Most Recent Source: The most recent source of information about an incident is bioMérieux.
.png)
A vulnerability was found in Nothings stb up to 1.26. Impacted is the function stbtt_InitFont_internal in the library stb_truetype.h of the component TTF File Handler. Performing a manipulation results in out-of-bounds read. Remote exploitation of the attack is possible. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.
V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read in VS6ComFile!get_macro_mem_COM. Opening a crafted V7 file may lead to information disclosure from the affected product.
V-SFT versions 6.2.10.0 and prior contain a stack-based buffer overflow in VS6ComFile!CSaveData::_conv_AnimationItem. Opening a crafted V7 file may lead to arbitrary code execution on the affected product.
V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read vulnerability in VS6MemInIF!set_temp_type_default. Opening a crafted V7 file may lead to information disclosure from the affected product.
V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read vulnerability in VS6ComFile!load_link_inf. Opening a crafted V7 file may lead to information disclosure from the affected product.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.